STERIS PUBLIC LIMITED COMPANY
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Miscellaneous Personal Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about STERIS PUBLIC LIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-01-22 (medicaldesignandoutsourcing.com)
Steris ethylene oxide trial ends in mistrial - Medical Design and Outsourcing
Steris this week announced that its jury trial against its subsidiary Isomedix Operations ended in a mistrial.
Read more
2025-01-21 (stocktitan.net)
STERIS Subsidiary's Ethylene Oxide Trial Ends in Mistrial After Juror Dismissal | STE Stock News
Personal injury case against STERIS's Isomedix unit over ethylene oxide emissions from 2005-2008 Waukegan facility faces retrial following jury reduction during deliberations.
Read more
2022-10-26 (communityadvocate.com)
STERIS, Northborough Planning Board case dismissed
STERIS Corp.’s appeal of the Northborough Planning Board’s permit denial, which has been before state Land Court, has been dismissed.
Read more
(law360.com)
Medtrica, Steris Prevail In Endoscopy Kit Patent Dispute -
A Washington federal judge ruled Monday that Medtrica Solutions Ltd. and Steris Corp. don't infringe Cygnus Medical LLC's patent for an endoscope precleaning kit, finding that the accused products don't satisfy one of the limitations in the asserted claims.
Read more